Skip to content

BD Vacutainer® PST™ Gel and Lithium HeparinN 83 Units 367962Recalls & reported problems

Becton, Dickinson And Company · BD Vacutainer® PST™ Gel and Lithium Heparin 83 Units · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This BD Vacutainer PST tube has 691 adverse event reports, with no deaths and 6 injuries. Common problems include inaccurate lab results, short fills and clotting, and some reports describe plastic protruding from the tube closure. 1 closed recall, started June 2019, covers falsely high carbon monoxide readings in blood gas tests on one analyzer. Reports dropped, with 37 in the last year compared with 69 in the year before.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
693
Deaths reported
0
Injuries reported
6
Recalls naming it
1

Summary

The FDA's MAUDE database contains 693 adverse event reports that list this exact device (DI 30382903679622), received between Oct 18, 2017 and Sep 30, 2026 — classified as 6 injuries, 687 malfunctions.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (267 reports).

1 FDA recall record name this device's identifier.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 5 reportsDec 2023: 9 reportsJan 2024: 7 reportsFeb 2024: 10 reportsMar 2024: 4 reportsApr 2024: 3 reportsMay 2024: 3 reportsJun 2024: 7 reportsJul 2024: 1 reportsAug 2024: 4 reportsSep 2024: 5 reportsOct 2024: 10 reportsNov 2024: 4 reportsDec 2024: 3 reportsJan 2025: 5 reportsFeb 2025: 0 reportsMar 2025: 5 reportsApr 2025: 8 reportsMay 2025: 10 reportsJun 2025: 0 reportsJul 2025: 11 reportsAug 2025: 14 reportsSep 2025: 7 reportsOct 2025: 2 reportsNov 2025: 8 reportsDec 2025: 3 reportsJan 2026: 0 reportsFeb 2026: 8 reportsMar 2026: 1 reportsApr 2026: 13 reportsMay 2026: 1 reportsJun 2026: 3 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 2 reportsOct 2026: 0 reports20242025202614
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Jun 12, 2019Class IITerminated

    False elevation of carboxyhemoglobin (COHb) results have been reported when using venous blood gas samples collected with tubes analyzed with the IL GEM 4000 instrument.

    Z-2303-2019 · Root cause: Device Design · Recall details · FDA record ↗

Most reported problems

Device problems

  • Incorrect, Inadequate or Imprecise Result or Readings267
  • Short Fill104
  • Device Ingredient or Reagent Problem64
  • Incorrect Or Inadequate Test Results53
  • Volume Accuracy Problem45
  • Leak/Splash40
  • Difficult to Insert31
  • Device Markings/Labelling Problem30

Patient problems

  • No Known Impact Or Consequence To Patient318
  • No Clinical Signs, Symptoms or Conditions297
  • No Consequences Or Impact To Patient34
  • No Information27
  • No Patient Involvement11
  • Hyperkalemia6
  • Hemolysis2
  • Hematoma1

Recent adverse event reports

The 25 most recent of 693 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 30, 2026Fluid/Blood Leak

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50951849 ↗
  • MalfunctionSep 28, 2026Incorrect, Inadequate or Imprecise Result or Readings

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50915151 ↗
  • MalfunctionJun 23, 2026Material Deformation

    IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, A PIECE OF PLASTIC WAS OBSERVED PROTRUDING FROM THE GATE ON THE HEMOGARD CLOSURE OF AN UNSPECIFIED NUMBER OF TUBES. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25598900 ↗
  • MalfunctionJun 18, 2026Incorrect, Inadequate or Imprecise Result or Readings

    PATIENT 2 OF 2: IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, ERRONEOUS ELEVATED TROPONIN RESULTS WERE REPORTED ON ONE PATIENT. THE SECOND SAMPLE IN THE SERIES WAS NORMAL. ADDITIONALLY, AFTER RE-CENTRIFUGING THE ORIGINAL SAMPLE, NORMAL RESULTS WERE OBTAINED. FIBRIN AND POOR BARRIER SEPARATION WERE ALSO REPORTED. THERE WAS NO HEALTH IMPACT OR CONSEQUENCES REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25549044 ↗
  • MalfunctionJun 18, 2026Incorrect, Inadequate or Imprecise Result or Readings

    PATIENT 1 OF 2: IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, ERRONEOUS ELEVATED TROPONIN RESULTS WERE REPORTED ON ONE PATIENT. THE SECOND SAMPLE IN THE SERIES WAS NORMAL. ADDITIONALLY, AFTER RE-CENTRIFUGING THE ORIGINAL SAMPLE, NORMAL RESULTS WERE OBTAINED. FIBRIN AND POOR BARRIER SEPARATION WERE ALSO REPORTED. THERE WAS NO HEALTH IMPACT OR CONSEQUENCES REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25549043 ↗
  • MalfunctionMay 5, 2026Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, ELEVATED AST LEVELS WERE RECEIVED FOR AN UNSPECIFIED NUMBER OF TUBES. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25086646 ↗
  • MalfunctionApr 30, 2026Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED THAT AFTER USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, ERRONEOUS RESULTS WERE SEEN WITH AN UNSPECIFIED NUMBER OF TUBES AFTER PATIENTS WERE INJECTED WITH DYE USED FOR CT SCANS. RECOLLECTION OCCURRED. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25051147 ↗
  • MalfunctionApr 30, 2026Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED THAT AFTER USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, ERRONEOUS RESULTS WERE SEEN WITH AN UNSPECIFIED NUMBER OF TUBES AFTER PATIENTS WERE INJECTED WITH DYE USED FOR CT SCANS. RECOLLECTION OCCURRED. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25051109 ↗
  • MalfunctionApr 23, 2026Device Ingredient or Reagent Problem

    IT WAS REPORTED AFTER USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARIN 83 UNITS, EIGHT (8) SAMPLES EXHIBITED CLOTTING. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24972859 ↗
  • MalfunctionApr 20, 2026Short Fill

    IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN (LH) 83 UNITS BLOOD COLLECTION TUBES, THE FILL VOLUME OF AN UNSPECIFIED NUMBER OF TUBES WAS NEAR ZERO. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24924806 ↗
  • MalfunctionApr 17, 2026Short Fill

    IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, AN UNSPECIFIED NUMBER OF TUBES UNDERFILLED. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24912796 ↗
  • MalfunctionApr 16, 2026Separation Problem

    IT WAS REPORTED THAT WHEN USING THE BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, THE STOPPER POPS OFF OF AN UNSPECIFIED NUMBER OF UNITS. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24905331 ↗
  • MalfunctionApr 8, 2026Device Ingredient or Reagent Problem

    IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARIN (LH) 83 UNITS BLOOD COLLECTION TUBES, THERE TWO (2) TUBES WITH POOR SEPARATION. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24818524 ↗
  • MalfunctionApr 3, 2026Incorrect, Inadequate or Imprecise Result or Readings

    REPORT 6 OF 6: IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARIN 83 UNITS, ERRONEOUS RESULTS- POTASSIUM WERE SEEN IN ONE (1) SAMPLE. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24777036 ↗
  • MalfunctionApr 2, 2026Incorrect, Inadequate or Imprecise Result or Readings

    REPORT 5 OF 6: IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARIN 83 UNITS, ERRONEOUS RESULTS- POTASSIUM WERE SEEN IN ONE (1) SAMPLE. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24772186 ↗
  • MalfunctionApr 2, 2026Incorrect, Inadequate or Imprecise Result or Readings

    REPORT 3 OF 6: IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARIN 83 UNITS, ERRONEOUS RESULTS- POTASSIUM WERE SEEN IN ONE (1) SAMPLE. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24772182 ↗
  • MalfunctionApr 2, 2026Incorrect, Inadequate or Imprecise Result or Readings

    REPORT 4 OF 6: IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARIN 83 UNITS, ERRONEOUS RESULTS- POTASSIUM WERE SEEN IN ONE (1) SAMPLE. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24772175 ↗
  • MalfunctionApr 2, 2026Incorrect, Inadequate or Imprecise Result or Readings

    REPORT 2 OF 6: IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARIN 83 UNITS, ERRONEOUS RESULTS- POTASSIUM WERE SEEN IN ONE (1) SAMPLE. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24772174 ↗
  • MalfunctionApr 2, 2026Incorrect, Inadequate or Imprecise Result or Readings

    REPORT 1 OF 6: IT WAS REPORTED WHILE USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARIN 83 UNITS, ERRONEOUS RESULTS- POTASSIUM WERE SEEN IN ONE (1) SAMPLE. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24772173 ↗
  • MalfunctionMar 17, 2026Separation Problem

    IT WAS REPORTED AFTER USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, THE STOPPER POPPED OFF ONE (1) TUBE. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24624078 ↗
  • MalfunctionFeb 24, 2026Separation Problem

    IT WAS REPORTED WHILE ATTEMPTING TO PULL BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, OUT OF THE HOLDER, THE STOPPER GOT STUCK AND SEPARATED FROM IT'S TUBE BODY. THIS OCCURRED WITH ONE TUBE. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24435603 ↗
  • MalfunctionFeb 18, 2026Device Ingredient or Reagent Problem

    IT WAS REPORTED PRIOR TO USING BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, AN UNSPECIFIED NUMBER OF TUBES CONTAINED GEL AIR BUBBLES. THERE WAS NO HEALTH IMPACT OR CONSEQUENCES REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24383896 ↗
  • MalfunctionFeb 18, 2026Device Ingredient or Reagent Problem

    IT WAS REPORTED PRIOR TO AND DURING USE OF BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, 10 TUBES EXHIBITED BUBBLES IN THE GEL SEPARATION BARRIER. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24378124 ↗
  • MalfunctionFeb 17, 2026Device Ingredient or Reagent Problem

    IT WAS REPORTED PRIOR TO AND DURING USE OF THE BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, THERE WERE BUBBLES IN THE GEL SEPARATION BARRIER OF 50 TUBES. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24373052 ↗
  • MalfunctionFeb 11, 2026Device Ingredient or Reagent Problem

    IT WAS REPORTED BEFORE AND DURING USE OF BD VACUTAINER® PST¿ GEL AND LITHIUM HEPARINN 83 UNITS, 15 TUBES EXHIBITED GEL AIR BUBBLES. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24314041 ↗

Other Tubes, vials, systems, serum separators, blood collection devices

All Tubes, vials, systems, serum separators, blood collection devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page